The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMGEN INC | COM | 031162100 | 15,212 | 87,477 | SH | SOLE | 87,477 | 0 | 0 | ||
AVIRAGEN THERAPEUTICS INC | COM | 053761102 | 1,591 | 2,809,531 | SH | SOLE | 2,809,531 | 0 | 0 | ||
BIOVERATIV INC | COM | 97075E100 | 39,376 | 730,260 | SH | SOLE | 730,260 | 0 | 0 | ||
CONMED CORP | COM | 207410101 | 8,387 | 164,547 | SH | SOLE | 164,547 | 0 | 0 | ||
DIGIRAD CORP | COM | 253827109 | 912 | 354,179 | SH | SOLE | 354,179 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 50,862 | 866,770 | SH | SOLE | 866,770 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 34,248 | 478,053 | SH | SOLE | 478,053 | 0 | 0 | ||
HALYARD HEALTH INC | COM | 40650V100 | 18,242 | 395,015 | SH | SOLE | 395,015 | 0 | 0 | ||
INVACARE CORP | COM | 461203101 | 18,666 | 1,107,770 | SH | SOLE | 1,107,770 | 0 | 0 | ||
JUNIPER PHARMACEUTICALS INC | COM | 48203L107 | 2,134 | 440,102 | SH | SOLE | 440,102 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 19,725 | 126,482 | SH | SOLE | 126,482 | 0 | 0 | ||
MERCK & CO. INC. | COM | 58933Y105 | 8,973 | 159,466 | SH | SOLE | 159,466 | 0 | 0 | ||
ORTHOFIX INTERNATIONAL NV | COM | N6748L102 | 17,742 | 324,357 | SH | SOLE | 324,357 | 0 | 0 | ||
RTI SURGICAL INC | COM | 74975N105 | 17,773 | 4,334,852 | SH | SOLE | 4,334,852 | 0 | 0 | ||
SUCAMPO PHARMACEUTICALS-CL A | COM | 864909106 | 23,414 | 1,304,376 | SH | SOLE | 1,304,376 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 43,561 | 294,429 | SH | SOLE | 294,429 | 0 | 0 |